American Healthcare REIT (NYSE:AHR) is a prominent player in the real estate investment trust sector, focusing on healthcare properties. The company invests in a diverse portfolio of healthcare facilities, including hospitals, nursing homes, and medical office buildings. AHR competes with other healthcare REITs, striving to provide investors with stable returns through rental income and property appreciation.
On August 28, 2025, Scotiabank set a price target of $47 for NYSE:AHR, suggesting a potential upside of 10.17% from its current trading price of $42.66. This target reflects confidence in AHR's growth prospects and aligns with the recent positive momentum in its stock price. Over the past week, AHR's stock has risen by 4.99%, attracting momentum investors who seek stocks with strong upward trends.
Momentum investing involves buying stocks that are on an upward trajectory, with the expectation that they will continue to rise. Zacks Investment Research has recognized AHR's strong performance by assigning it a Momentum Style Score of A. This score indicates that AHR is a favorable choice for investors employing momentum-based strategies, as highlighted by Zacks Investment Research.
Despite a slight decrease of 0.14% or $0.06 in its current stock price to $42.67, AHR's recent performance suggests it may continue on its upward path. The stock has traded between $42.44 and $42.77 today, with a 52-week high of $43.14 and a low of $20.15. AHR's market capitalization is approximately $7.19 billion, with a trading volume of 249,296 shares on the NYSE.
